Compare Aurora Cannabis Inc (ACB) vs NetFlix Inc (NFLX) Price & Performance

Aurora Cannabis (ACB) trades at $2.71, down 4.58% on the day, with a bearish technical outlook. The company reported a net income of $1.59 million in 2025, a significant improvement from a $69 million loss in 2024, though 2026 guidance projects a net loss of $136 million. Revenue grew to $343.29 million in 2025, but faces headwinds from Canadian reimbursement pressures. Analyst consensus is mixed, with 21.43% buy, 57.14% hold, and 21.43% sell ratings.

The stock's low P/B of 0.47 suggests undervaluation, but negative profitability metrics and a projected reset year in 2027 pose risks. Investment appeal hinges on execution in high-margin international medical markets, though volatility and competitive pressures remain key concerns for shareholders.

Netflix (NFLX) trades at $76.02, down 2.1% amid a bearish technical trend, though fundamentals remain strong with 2025 revenue of $45.18B and net income of $10.98B. The stock is near its 52-week low, with support at $75 and resistance at $77. Recent Q1 2026 earnings beat expectations with EPS of $1.23 versus $0.76 expected, highlighting robust operational performance despite market pessimism.

The outlook is mixed: strong fundamentals and a consensus price target of $114.75 suggest 51% upside, but technical weakness and competitive pressures pose risks. Investors should weigh the company's high ROE of 48.5% and scaling ad business against market sentiment and recent stock declines.